Change of Adviser

RNS Number : 5948Q

e-Therapeutics plc

01 March 2021

 

e-therapeutics plc

("e-therapeutics" or the "Company")

Change of Adviser

Oxford, UK, 1 March 2021 - e-therapeutics plc (AIM: ETX) is pleased to announce the appointment of SP Angel Corporate Finance LLP as the Company's Nominated Adviser and Broker, with immediate effect.

Director Disclosure

The Company also announces the following additional information in accordance with paragraph (g) of Schedule Two to the AIM Rules for Companies in respect of Ali Mortazavi, CEO of the Company. Mr Mortazavi is a current LLP Member of Arcade Films 4 LLP and was at the time of his appointment to the Board on 11 February 2020.

Enquiries:

e-therapeutics plc
Ali Mortazavi, CEO	Tel: [phone]
	www.etherapeutics.co.uk
SP Angel Corporate Finance LLP	Tel: [phone]
Nominated Adviser and Broker
Matthew Johnson/Caroline Rowe (Corporate Finance)
Vadim Alexandre/Rob Rees (Corporate Broking)

About e-therapeutics plc

e-therapeutics plc is an Oxford, UK-based company with a powerful computer-based approach to drug discovery, founded on its industry-leading expertise in network biology to fully capture disease complexity. The Company combines network science, machine learning, artificial intelligence, statistics and big data with expertise in drug discovery and development to transform the search for new medicines and intervention strategies.

e-therapeutics has developed an in silico laboratory that enables the rapid screening of millions of compounds and the identification of small sub-sets that are enriched for highly active hits. Its proprietary platform also has novel applications in functional genomics, being able to analyse complex genetic datasets, provide a deep understanding of pathological mechanisms and distil actionable insights for the discovery of novel drugs, biomarkers and diagnostics.

e-therapeutics has deployed and validated its disease-agnostic drug discovery platform both in house and with partners, including Novo Nordisk, Galapagos NV and a US-based, top 5 pharmaceutical company.

 

END

 

 

APPBQLLLFLLXBBV